274 related articles for article (PubMed ID: 7817772)
1. Impaired interleukin-8-dependent chemotaxis by synovial fluid polymorphonuclear leukocytes in rheumatoid arthritis.
Hashimoto H; Yamamura M; Nishiya K; Ota Z
Acta Med Okayama; 1994 Aug; 48(4):181-7. PubMed ID: 7817772
[TBL] [Abstract][Full Text] [Related]
2. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
[TBL] [Abstract][Full Text] [Related]
3. Synovial fluid polymorphonuclear leucocytes from patients with rheumatoid arthritis have reduced MPO and NADPH-oxidase activity.
Davies EV; Williams BD; Campbell AK
Br J Rheumatol; 1990 Dec; 29(6):415-21. PubMed ID: 2175239
[TBL] [Abstract][Full Text] [Related]
4. Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis.
Koch AE; Kunkel SL; Harlow LA; Mazarakis DD; Haines GK; Burdick MD; Pope RM; Walz A; Strieter RM
J Clin Invest; 1994 Sep; 94(3):1012-8. PubMed ID: 8083342
[TBL] [Abstract][Full Text] [Related]
5. Synovial PMN show a coordinated up-regulation of CD66 molecules.
Hönig M; Peter HH; Jantscheff P; Grunert F
J Leukoc Biol; 1999 Sep; 66(3):429-36. PubMed ID: 10496313
[TBL] [Abstract][Full Text] [Related]
6. Chemotactic activity for polymorphonuclear and mononuclear leukocytes in rheumatoid synovial fluids.
Okamoto T; Ueda K; Kambara T; Kutsuna T
Acta Pathol Jpn; 1986 Aug; 36(8):1109-22. PubMed ID: 3776528
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis: findings in a prospective, randomized, double-blind clinical trial in fifteen patients.
Kraan MC; de Koster BM; Elferink JG; Post WJ; Breedveld FC; Tak PP
Arthritis Rheum; 2000 Jul; 43(7):1488-95. PubMed ID: 10902750
[TBL] [Abstract][Full Text] [Related]
8. [Chemotactic response of polymorphonuclear neutrophil to FMLP and IL-8 in rapidly progressive periodontitis patients].
Liu R; Cao C
Zhonghua Kou Qiang Yi Xue Za Zhi; 1998 Nov; 33(6):335-7. PubMed ID: 11774434
[TBL] [Abstract][Full Text] [Related]
9. Enhanced oxidative response of polymorphonuclear leukocytes from synovial fluids of patients with rheumatoid arthritis.
Dularay B; Elson CJ; Dieppe PA
Autoimmunity; 1988; 1(3):159-69. PubMed ID: 2856511
[TBL] [Abstract][Full Text] [Related]
10. Effect of piroxicam therapy on granulocyte function and granulocyte elastase concentration in peripheral blood and synovial fluid of rheumatoid arthritis patients.
Montecucco C; Mazzone A; Pasotti D; Caporali R; Longhi M; Casilli D; Ricevuti G; Fratino P; Ruffilli MP
Inflammation; 1989 Apr; 13(2):211-20. PubMed ID: 2547713
[TBL] [Abstract][Full Text] [Related]
11. Abnormal directed migration of blood polymorphonuclear leukocytes in rheumatoid arthritis. Potential role in increased susceptibility to bacterial infections.
Aglas F; Hermann J; Egger G
Mediators Inflamm; 1998; 7(1):19-23. PubMed ID: 9839694
[TBL] [Abstract][Full Text] [Related]
12. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
[TBL] [Abstract][Full Text] [Related]
13. Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators.
Katona IM; Ohura K; Allen JB; Wahl LM; Chenoweth DE; Wahl SM
J Immunol; 1991 Jan; 146(2):708-14. PubMed ID: 1898961
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil chemotactic heterogeneity to N-formyl-methionyl-leucyl-phenylalanine detected by the under-agarose assay.
Quitt M; Torres M; McGuire W; Beyer L; Coates TD
J Lab Clin Med; 1990 Feb; 115(2):159-64. PubMed ID: 2299263
[TBL] [Abstract][Full Text] [Related]
15. Potential of a 70 kDa IL-10-like factor in synovial fluid from rheumatoid arthritis patients to augment superoxide generation by human neutrophils.
Nakamura T; Yamamoto T
Int J Rheum Dis; 2016 Feb; 19(2):150-8. PubMed ID: 24119062
[TBL] [Abstract][Full Text] [Related]
16. Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.
Brennan FM; Zachariae CO; Chantry D; Larsen CG; Turner M; Maini RN; Matsushima K; Feldmann M
Eur J Immunol; 1990 Sep; 20(9):2141-4. PubMed ID: 2209707
[TBL] [Abstract][Full Text] [Related]
17. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
Charo IF; Yuen C; Perez HD; Goldstein IM
J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
[TBL] [Abstract][Full Text] [Related]
18. Chemotaxis and chemiluminescence responses of synovial fluid polymorphonuclear leucocytes during acute reactive arthritis.
Leirisalo-Repo M; Lauhio A; Repo H
Ann Rheum Dis; 1990 Aug; 49(8):615-9. PubMed ID: 2396867
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
Perez HD; Elfman F; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
[TBL] [Abstract][Full Text] [Related]
20. An indirect bioluminescence method for the quantitative measurement of polymorphonuclear cell chemotaxis.
Partsch G; Schwarzer C
J Biolumin Chemilumin; 1991; 6(3):159-67. PubMed ID: 1660670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
